Table 1.
Day of Therapy | i.v. Dalbavancin, mg | SBA Titers | Dalbavancin Serum Concentration, mg/L |
---|---|---|---|
Day 1 | 1500 | n.a. | n.a. |
Day 7 | 1500 | n.a. | n.a. |
Day 42 | 1500 | 1:128b | n.a. |
Day 63 | Not administered | 1:512 | 32.8c |
Day 112 | 1500 | 1:8b | 0.6c (410.5d) |
Day 133 | Not administered | 1:128 | 17.9c |
Day 154 | Not administered | 1:16 | n.a |
Day 189 | 1500 | 1:2b | n.a. |
Abbreviations: i.v., intravenous; SBA, serum bactericidal activity.
aAfter day 42, it was decided to administer dalbavancin whenever an SBA titer ≤1:8 was detected; these circumstances accounted for through SBA titers previously reported as resulting in bacteriological cure in infective endocarditis [5].
bSBA titer before i.v. dalbavancin administration.
cThrough serum drug concentration.
dPeak serum drug concentration (measured 15 minutes after dalbavancin i.v. administration).